FDA NDC Directory · JSON-LD · Markdown

BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

NDC 76420-534 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAsclemed USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA209069
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE HYDROCHLORIDE (8 mg/1)
NALOXONE HYDROCHLORIDE DIHYDRATE (2 mg/1)
Marketing started20210122
Package count1

External sources

Source: openFDA. Public-domain (CC0).